Effect of maitake (Grifola frondosa) D-Fraction on the control of the T lymph node Th-1/Th-2 proportion

Biological and Pharmaceutical Bulletin

Volumn 25, Issue 4, 2002, Pages 536-540

  Inoue, Atsuyuki ^a   Kodama, Noriko ^a   Nanba, Hiroaki ^a  

^a KOBE PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Maitake; Polysaccharide (D Fraction); Th 1 Th 2 cells

Indexed keywords

GAMMA INTERFERON; GRIFOLA FRONDOSA EXTRACT; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 4; PLANT EXTRACT; PROTEIN P70; UNCLASSIFIED DRUG; CYTOKINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; B LYMPHOCYTE ACTIVATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; GRIFOLA FRONDOSA; INTERFERON PRODUCTION; LYMPH NODE CELL; MOUSE; MUSHROOM; NONHUMAN; SPLEEN CELL; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH2 CELL; AGARICALES; ANIMAL; B LYMPHOCYTE; BIOSYNTHESIS; C3H MOUSE; CARCINOMA; CD4+ T LYMPHOCYTE; CYTOLOGY; DRUG EFFECT; DRUG SCREENING; IMMUNOLOGY; LYMPH NODE; LYMPHOCYTE ACTIVATION; MALE; METABOLISM; METHODOLOGY; SPLEEN; STATISTICS;

AGARICALES; ANIMALS; B-LYMPHOCYTES; CARCINOMA; CD4-POSITIVE T-LYMPHOCYTES; CYTOKINES; INTERFERON TYPE II; INTERLEUKIN-12; INTERLEUKIN-18; INTERLEUKIN-4; LYMPH NODES; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED C3H; PLANT EXTRACTS; SPLEEN; T-LYMPHOCYTE SUBSETS; TH1 CELLS; TH2 CELLS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 0036545424     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.25.536     Document Type: Article

References (19)

1. Mosmann T. R., Cherwinski H., Bond M. W., Giedlin M. A., Coffman R. L., J. Immunol., 136, 2348-2357 (1986).
2. Mosmann T. R., Coffman R. L., Annu. Rev. Immunol., 7, 145-173 (1989).
3. Okamura H., Tsutsui H., Komatsu T., Yutsudo M., Hakura A., Tanimoto T., Torigoe K., Okura T., Nukada Y., Hattori K., Nature (London), 378, 88-91 (1995).
4. Micallef M. J., Ohtsuki T., Kohno K., Tanabe F., Ushio S., Namha M., Tanimoto T., Torigoe K., Fujii M., Ikeda M., Fukuda S., Kurimoto M., Eur. J. Immunol., 26, 1647-1651 (1996).
5. Cohen P. A., Cohen P. J., Rosenberg S. A., Mule J. J., Cancer Res., 54, 1055-1058 (1994).
6. Nanba H., Hamaguchi A., Kuroda H., Chem. Pharm. Bull., 35, 1162-1168 (1987).
7. Adachi K., Nanba H., Kuroda H., Chem. Pharm. Bull., 35, 262-270 (1987).
8. Hishida I., Nanba H., Kuroda H., Chem. Pharm. Bull., 36, 1819-1827 (1988).
9. Shigesue K., Kodama N., Nanba H., Jpn. J. Pharmacol., 84, 293-300 (2000).
10. Jung T., Schauer U., Heusser C., Neumann C., Rieger C., J. Immunol. Methods, 159, 197-207 (1993).
11. Nishimura T., Kitamura H., Iwakabe K., Yahata T., Ohta A., Sato M., Takeda K., Okumura K., Van Kaer L., Kawano T., Taniguchi M., Nakui M., Sekimoto M., Koda T., Int. Immunol., 12, 987-994 (2000).
12. Trinchieri G., Immunol. Today, 14, 335-338 (1993).
13. Nakanishi K., Yoshimoto T., Tsutsui H., Okamura H., Cytokine Growth Factor Rev., 12, 53-72 (2001).
14. Sasakura S. (ed.), "Cytokine," Nihon Igakukan, Japan, 1997.
15. Tsutsui H., Nakanishi K., Matsui K., Higashino K., Okamura H., Miyazawa Y., Kaneda K., J. Immunol., 157, 3967-3973 (1996).
16. Dao T., Ohashi K., Kayano T., Kurimoto M., Okamura H., Cell Immunol., 173, 230-235 (1996).
17. Yoshimoto T., Tsutsui H., Tominaga K., Hoshino K., Okamura H., Akira S., Paul W. E., Nakanishi K., Proc. Natl. Acad. Sci. U.S.A., 96, 13962-13966 (1999).
18. Yamanaka K., Tanaka M., Tsutsui H., Kupper T. S., Asahi K., Okamura H., Nakanishi K., Suzuki M., Kayagaki N., Black R. A., Miller D. K., Nakashima K., Shimizu M., Mizutani H., J. Immunol., 165, 997-1003 (2000).
19. Szabo S. J., Jacobson N. G., Dighe A. S., Gubler U., Murphy K. M., Immunity, 2, 665-675 (1995).